There are currently 117 active clinical trials seeking participants for Schizophrenia research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and New York.
Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness
Recruiting
Chronic pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic pain leads to poorer mental health and physical functioning, and represents a critical obstacle to rehabilitation and recovery. Despite known high prevalence rates of chronic pain in SMI populations, there is little research to: a) evaluate nonpharmacological pain management strategies in this population, and b) examine directional relations between chronic pain and SMI symptoms. Th... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/18/2024
Locations: Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore, Maryland
Conditions: Chronic Pain, Schizophrenia, Psychotic Disorders, Bipolar Disorder, Affective Disorders, Psychotic
Acetazolamide for Treatment Resistant Schizophrenia
Recruiting
This is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
01/04/2024
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania +1 locations
Conditions: Schizophrenia, Schizo Affective Disorder
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Recruiting
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
01/04/2024
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania
Conditions: Schizophrenia, Schizo Affective Disorder
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Recruiting
This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and healthy controls.
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
12/15/2023
Locations: McLean Hospital, Belmont, Massachusetts
Conditions: Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Recruiting
Kynurenic acid (KYNA) is a naturally occurring chemical in the brain. Studies with rodents indicate that levels of KYNA can impact levels of the neurotransmitters glutamate and dopamine. One way to reliably increase KYNA levels is by ingesting the amino acid tryptophan. Tryptophan is a normal part of the human diet. Tryptophan gets metabolized/changed to other chemicals in the body- including KYNA. By giving people 6 grams of tryptophan, the investigators will be able to increase the KYNA level... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
12/14/2023
Locations: Maryland Psychiatric Research Center (MPRC) ; the Treatment Research Program (TRP), Catonsville, Maryland
Conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
Cerebellar Stimulation and Cognitive Control
Recruiting
The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
12/11/2023
Locations: University of Iowa, Iowa City, Iowa
Conditions: Schizophrenia, Autism Spectrum Disorder, Bipolar Disorder, Depression, Parkinson Disease
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
Recruiting
This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory activity, and EEG will record the responses of EC-SCZ participants. A working memory task will also be incorporated in order to determine how DLPFC natural frequency (NF) is related to working memory p... Read More
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
12/04/2023
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania
Conditions: Schizophrenia
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
Recruiting
Many individuals with serious mental illness have difficulty accurately interpreting interpersonal cues and effectively engaging in social exchanges. Difficulties related to the interpersonal aspects of work can lead to isolation, poor productivity, and job loss. The goals of this study are to: 1) adapt an evidence-based social cognitive skills intervention for work settings and use with Veterans, 2) examine the acceptability of the work focused skills training intervention, 3) assess the feasib... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/30/2023
Locations: Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota
Conditions: Schizophrenia, Bipolar Disorder, Depressive Disorder, Major, Stress Disorder, Post-Traumatic
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
Recruiting
The purpose of this study is to better understand mental illness and will test the hypotheses that while viewing affective stimuli, patient groups will show increased blood oxygenation level dependent (BOLD) signal by fMRI after lorazepam. This study will enroll participants between the ages of 16 and 60, who have a psychotic illness (such as psychosis which includes conditions like schizophrenia, schizoaffective disorder, and mood disorders). The study will also enroll eligible participants wi... Read More
Gender:
All
Ages:
Between 16 years and 60 years
Trial Updated:
11/30/2023
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Schizophrenia, Bipolar Disorder, Healthy, Psychosis, Schizophreniform Disorders, Schizo Affective Disorder, Major Depression With Psychotic Features
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
Recruiting
This project will conduct a confirmatory efficacy trial of two novel psychosocial interventions, Cognitive Enhancement Therapy and Enriched Supportive Therapy, for the treatment of persistent negative symptoms in schizophrenia.
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
11/20/2023
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania
Conditions: Schizophrenia
Effects of Brain Stimulation on Higher-Order Cognition
Recruiting
The purpose of this study is to better understand the neural correlates of higher-order cognition, both in the healthy brain and in schizophrenia, and to determine how these mechanisms are modulated by transcranial direct current stimulation (tDCS) at frontal and occipital scalp sites. Testing the effects of tDCS at these scalp sites on cognitive task performance will help us understand the roles of the brain regions corresponding to these sites during higher-order cognitive processing (language... Read More
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
11/20/2023
Locations: Imaging Research Center, Sacramento, California
Conditions: Schizophrenia
Imaging Synapses With [11C] UCB-J in the Human Brain
Recruiting
The purpose of this study is to utilize the radioactive positron emission tomography (PET) tracer [11C]UCB-J to test the neural synaptic pruning hypothesis of schizophrenia. This imaging method allows for the quantification of synaptic density in the living human brain and has the unprecedented ability to directly examine the synaptic pathology underlying neuropsychiatric disease. The neural synaptic pruning hypothesis posits that a key pathogenic process of schizophrenia is the over-exuberant e... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/15/2023
Locations: VA Palo Alto Health Care System, Palo Alto, California +1 locations
Conditions: Schizophrenia